Common Contracts
8 similar Purchase Agreement contracts by CSG Systems International Inc, Immunogen Inc, Lyft, Inc., others
Lyft, Inc. Purchase AgreementPurchase Agreement • February 28th, 2024 • Lyft, Inc. • Services-business services, nec • New York
Lyft, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $400,000,000 principal amount of its 0.625% Convertible Senior Notes due 2029 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $60,000,000 principal amount of its 0.625% Convertible Senior Notes due 2029 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 0.625% Convertible Senior Notes due 2029 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. Upon conversion, the Company will pay cash up to the aggregate principal amount of the Securities to be converted and pay or deliver, as the case may be, cash, shares (the “Underl
PURCHASE AGREEMENT United States Steel Corporation $300,000,000 5.00% Senior Convertible Notes due 2026Purchase Agreement • October 21st, 2019 • United States Steel Corp • Steel works, blast furnaces & rolling mills (coke ovens) • New York
United States Steel Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom Goldman Sachs & Co. LLC and Barclays Capital Inc. are acting as representatives (the “Representatives”), $300,000,000 aggregate principal amount of its 5.00% Senior Convertible Notes due 2026 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $50,000,000 principal amount of 5.00% Senior Convertible Notes due 2026 (the “Option Securities”). The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into shares (the “Underlying Securities”) of common stock, par value $1.00 per share, of the Company (the “Common Stock”). The Securities will be issued pursuant to an indenture to be dated as of October 21, 2019 (the “Indenture”) between the Company and The Bank of New York Mel
PURCHASE AGREEMENT IMMUNOGEN, INC. Purchase AgreementPurchase Agreement • June 20th, 2016 • Immunogen Inc • Pharmaceutical preparations • New York
ImmunoGen, Inc., a Massachusetts corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $100,000,000 principal amount of its 4.50% Convertible Senior Notes due 2021 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $15,000,000 principal amount of its 4.50% Convertible Senior Notes due 2021 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 4.50% Convertible Senior Notes due 2021 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into shares (the “Underlying Securities”) of common stock of the Company, par value $0.01 per share (the “Common Stock”). The Securities wi
PURCHASE AGREEMENTPurchase Agreement • March 15th, 2016 • CSG Systems International Inc • Services-computer processing & data preparation • New York
CSG Systems International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $200,000,000 principal amount of its 4.25% Senior Convertible Notes due 2036 (the “Firm Securities”) and, at the option of the Initial Purchasers, up to an additional $30,000,000 principal amount of its 4.25% Senior Convertible Notes due 2036 (the “Option Securities”) solely to cover over-allotments, if any, if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 4.25% Senior Convertible Notes due 2036 granted to the Initial Purchasers solely to cover over-allotments, if any, in Section 2 hereof. The Firm Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, shares (the “Underlying Securities”) of common s
TRULIA, INC. Purchase Agreement December 11, 2013Purchase Agreement • December 17th, 2013 • Trulia, Inc. • Services-computer processing & data preparation • New York
RAMBUS INC.Purchase Agreement • August 16th, 2013 • Rambus Inc • Semiconductors & related devices • New York
Rambus Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $120,000,000 aggregate principal amount of its 1.125% Convertible Senior Notes due 2018 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $18,000,000 aggregate principal amount of its 1.125% Convertible Senior Notes due 2018 (the “Option Securities”), solely to cover overallotments, if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such Option Securities granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, and if designated by the Company, shares (the “Underlying Securities”) of common stock of the Company,
WRIGHT MEDICAL GROUP, INC. Purchase AgreementPurchase Agreement • August 28th, 2012 • Wright Medical Group Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
Wright Medical Group, Inc., a Delaware corporation (herein called the “Company” which term shall include its direct and indirect subsidiaries unless the context otherwise requires), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $260,000,000 principal amount of its 2.00% Cash Convertible Senior Notes due 2017 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $40,000,000 principal amount of its 2.00% Cash Convertible Senior Notes due 2017 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 2.00% Cash Convertible Senior Notes due 2017 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be issued pursuant
CSG Systems International, Inc. PURCHASE AGREEMENTPurchase Agreement • March 2nd, 2010 • CSG Systems International Inc • Services-computer processing & data preparation • New York
CSG Systems International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $130,000,000 principal amount of its 3.0% Senior Subordinated Convertible Notes due 2017 (the “Firm Securities”) and, at the option of the Initial Purchasers, up to an additional $20,000,000 principal amount of its 3.0% Senior Subordinated Convertible Notes due 2017 (the “Option Securities”) solely to cover over-allotments, if any, if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 3.0% Senior Subordinated Convertible Notes due 2017 granted to the Initial Purchasers solely to cover over-allotments, if any, in Section 2 hereof. The Firm Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into shares (the “Underl
